Page last updated: 2024-08-18

pyridostigmine bromide and Neuromyelitis Optica

pyridostigmine bromide has been researched along with Neuromyelitis Optica in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Bong, JB; Kang, HG; Lee, MA	1
Adamu, MD; Balarabe, SA; Jiya, N; Watila, MM	1
Akman-Demir, G; de Seze, J; Franciotta, D; Jarius, S; Kristoferitsch, W; Liebetrau, M; Melms, A; Münch, C; Paul, F; Ruprecht, K; Salvetti, M; Wandinger, KP; Wildemann, B	1

Reviews

1 review(s) available for pyridostigmine bromide and Neuromyelitis Optica

Article	Year
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Multiple sclerosis (Houndmills, Basingstoke, England), 2012, Volume: 18, Issue:8 Topics: Adolescent; Adult; Aquaporin 4; Autoantibodies; Child; Cholinesterase Inhibitors; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myasthenia Gravis; Neuromyelitis Optica; Oligoclonal Bands; Pyridostigmine Bromide; Retrospective Studies; Risk Assessment; Risk Factors; Thymectomy; Time Factors; Treatment Outcome; White People; Young Adult	2012

Article

Year

Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.

Multiple sclerosis (Houndmills, Basingstoke, England), 2012, Volume: 18, Issue:8

Topics: Adolescent; Adult; Aquaporin 4; Autoantibodies; Child; Cholinesterase Inhibitors; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myasthenia Gravis; Neuromyelitis Optica; Oligoclonal Bands; Pyridostigmine Bromide; Retrospective Studies; Risk Assessment; Risk Factors; Thymectomy; Time Factors; Treatment Outcome; White People; Young Adult

2012

Other Studies

2 other study(ies) available for pyridostigmine bromide and Neuromyelitis Optica

Article	Year
Newly diagnosed multiple sclerosis in a patient with ocular myasthenia gravis: A case report. Medicine, 2022, Feb-25, Volume: 101, Issue:8 Topics: Antibodies; Brain; Cholinesterase Inhibitors; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Myasthenia Gravis; Myelitis; Neuromyelitis Optica; Optic Neuritis; Pyridostigmine Bromide	2022
Neuromyelitis optica and myasthenia gravis in a young Nigerian girl. BMJ case reports, 2015, Sep-03, Volume: 2015 Topics: Adolescent; Anti-Inflammatory Agents; Autoantibodies; Cholinesterase Inhibitors; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Methylprednisolone; Myasthenia Gravis; Neuromyelitis Optica; Nigeria; Paraparesis, Spastic; Pyridostigmine Bromide; Spinal Cord; Treatment Outcome	2015

Article

Year

Newly diagnosed multiple sclerosis in a patient with ocular myasthenia gravis: A case report.

Medicine, 2022, Feb-25, Volume: 101, Issue:8

Topics: Antibodies; Brain; Cholinesterase Inhibitors; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Myasthenia Gravis; Myelitis; Neuromyelitis Optica; Optic Neuritis; Pyridostigmine Bromide

2022

Neuromyelitis optica and myasthenia gravis in a young Nigerian girl.

BMJ case reports, 2015, Sep-03, Volume: 2015

Topics: Adolescent; Anti-Inflammatory Agents; Autoantibodies; Cholinesterase Inhibitors; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Methylprednisolone; Myasthenia Gravis; Neuromyelitis Optica; Nigeria; Paraparesis, Spastic; Pyridostigmine Bromide; Spinal Cord; Treatment Outcome

2015